F2 and colorectal carcinoma: This study aims to assess key coagulation markers—fibrinogen, d-dimer, activated partial thromboplastin time, prothrombin time, prothrombin activity, thrombin time, platelet count, and international normalized ratio—to evaluate their potential in determining CRC aggressiveness.